FALCON’s TRILOGY PLATFORM TECHNOLOGY
At the forefront of
personalized cell therapy for solid tumor cancers
Falcon Therapeutics’ proprietary Trilogy Cells hunt, home, and kill hard to reach cancers. We convert a patient’s own skin into tumor-killing machines.
READ MORE
Our Team
Meet our high-powered, experienced team dedicated to improving patients’ lives through groundbreaking science
Susan Nichols
President and CEO
Bruce McCreedy
Acting CSO
Rhonda Stanley
CFO
Joy Cavagnaro
Founder and Regulatory Lead
Kevin Sheets
Product Development Lead
Shawn Hingtgen
Founder
Contact Us
Have a question or comment for us? Reach out and we’ll get in touch as soon as we can.